Bonsack B et al. (2020), Fast-tracking regenerative medicine for traumat...

ECB-ART-48638

Neural Regen Res 2020 Jul 01;157:1179-1190. doi: 10.4103/1673-5374.270294.

Show Gene links Show Anatomy links

Fast-tracking regenerative medicine for traumatic brain injury.

Bonsack B , Heyck M , Kingsbury C , Cozene B , Sadanandan N , Lee JY , Borlongan CV .

???displayArticle.abstract???
Traumatic brain injury remains a global health crisis that spans all demographics, yet there exist limited treatment options that may effectively curtail its lingering symptoms. Traumatic brain injury pathology entails a progression from primary injury to inflammation-mediated secondary cell death. Sequestering this inflammation as a means of ameliorating the greater symptomology of traumatic brain injury has emerged as an attractive treatment prospect. In this review, we recapitulate and evaluate the important developments relating to regulating traumatic brain injury-induced neuroinflammation, edema, and blood-brain barrier disintegration through pharmacotherapy and stem cell transplants. Although these studies of stand-alone treatments have yielded some positive results, more therapeutic outcomes have been documented from the promising area of combined drug and stem cell therapy. Harnessing the facilitatory properties of certain pharmaceuticals with the anti-inflammatory and regenerative effects of stem cell transplants creates a synergistic effect greater than the sum of its parts. The burgeoning evidence in favor of combined drug and stem cell therapies warrants more elaborate preclinical studies on this topic in order to pave the way for later clinical trials.

???displayArticle.pubmedLink??? 31960797
???displayArticle.pmcLink??? PMC7047809
???displayArticle.link??? Neural Regen Res

Genes referenced: LOC115919910

???attribute.lit??? ???displayArticles.show???

References [+] :

Acosta, Combination therapy of human umbilical cord blood cells and granulocyte colony stimulating factor reduces histopathological and motor impairments in an experimental model of chronic traumatic brain injury. 2014, Pubmed
Acosta, Alpha-synuclein as a pathological link between chronic traumatic brain injury and Parkinson's disease. 2015, Pubmed
Acosta, Intravenous Bone Marrow Stem Cell Grafts Preferentially Migrate to Spleen and Abrogate Chronic Inflammation in Stroke. 2015, Pubmed
Altanerova, Exosomes of human mesenchymal stem/stromal/medicinal signaling cells. 2017, Pubmed
Amin, A novel mechanism of action of tetracyclines: effects on nitric oxide synthases. 1996, Pubmed
Antonucci, Human second trimester amniotic fluid cells are able to create embryoid body-like structures in vitro and to show typical expression profiles of embryonic and primordial germ cells. 2014, Pubmed
Antonucci, Amniotic fluid stem cells: a promising therapeutic resource for cell-based regenerative therapy. 2012, Pubmed
Bath, Colony stimulating factors (including erythropoietin, granulocyte colony stimulating factor and analogues) for stroke. 2013, Pubmed
Borlongan, Intracerebral xenografts of mouse bone marrow cells in adult rats facilitate restoration of cerebral blood flow and blood-brain barrier. 2004, Pubmed
Borlongan, The great migration of bone marrow-derived stem cells toward the ischemic brain: therapeutic implications for stroke and other neurological disorders. 2011, Pubmed
Borlongan, Bone marrow stem cell mobilization in stroke: a 'bonehead' may be good after all! 2011, Pubmed
Brandau, Tissue-resident mesenchymal stem cells attract peripheral blood neutrophils and enhance their inflammatory activity in response to microbial challenge. 2010, Pubmed
Chen, Neural stem cells over-expressing brain-derived neurotrophic factor promote neuronal survival and cytoskeletal protein expression in traumatic brain injury sites. 2017, Pubmed
Chiossone, Mesenchymal Stromal Cells Induce Peculiar Alternatively Activated Macrophages Capable of Dampening Both Innate and Adaptive Immune Responses. 2016, Pubmed
Cho, Mesenchymal stem cells reciprocally regulate the M1/M2 balance in mouse bone marrow-derived macrophages. 2014, Pubmed
Colmano, Effect of metyrapone and DDD on infectious diseases. 1971, Pubmed
Cox, Autologous bone marrow mononuclear cell therapy for severe traumatic brain injury in children. 2011, Pubmed
Cox, Treatment of Severe Adult Traumatic Brain Injury Using Bone Marrow Mononuclear Cells. 2017, Pubmed
De La Peña, G-CSF as an adjunctive therapy with umbilical cord blood cell transplantation for traumatic brain injury. 2015, Pubmed
Dekmak, Stem cells and combination therapy for the treatment of traumatic brain injury. 2018, Pubmed
Ding, Melatonin stimulates antioxidant enzymes and reduces oxidative stress in experimental traumatic brain injury: the Nrf2-ARE signaling pathway as a potential mechanism. 2014, Pubmed
Ding, Melatonin reduced microglial activation and alleviated neuroinflammation induced neuron degeneration in experimental traumatic brain injury: Possible involvement of mTOR pathway. 2014, Pubmed
Duan, Functional hyaluronate collagen scaffolds induce NSCs differentiation into functional neurons in repairing the traumatic brain injury. 2016, Pubmed
Geng, Mesenchymal stem cells ameliorate rhabdomyolysis-induced acute kidney injury via the activation of M2 macrophages. 2014, Pubmed
Ghazale, Docosahexaenoic acid (DHA) enhances the therapeutic potential of neonatal neural stem cell transplantation post-Traumatic brain injury. 2018, Pubmed
Gonzalez, Erythropoietin enhances long-term neuroprotection and neurogenesis in neonatal stroke. 2007, Pubmed
Guo, Peptide YY inhibits the insulinotropic action of gastric inhibitory polypeptide. 1989, Pubmed
Guo, Rescuing macrophage normal function in spinal cord injury with embryonic stem cell conditioned media. 2016, Pubmed
Guo, Protection of minocycline on early brain injury after subarachnoid hemorrhage in rats. 2011, Pubmed
Hara, Neural progenitor NT2N cell lines from teratocarcinoma for transplantation therapy in stroke. 2008, Pubmed
Hirschenfang, Personality patterns in peripheral neuropathy. 1968, Pubmed
Homsi, Minocycline effects on cerebral edema: relations with inflammatory and oxidative stress markers following traumatic brain injury in mice. 2009, Pubmed
Hu, Calpain inhibitor MDL28170 improves the transplantation-mediated therapeutic effect of bone marrow-derived mesenchymal stem cells following traumatic brain injury. 2019, Pubmed
Jahnke, Maternal and developmental toxicity evaluation of melatonin administered orally to pregnant Sprague-Dawley rats. 1999, Pubmed
Jia, Recombinant PEP-1-SOD1 improves functional recovery after neural stem cell transplantation in rats with traumatic brain injury. 2018, Pubmed
Kaneko, Human amniotic epithelial cells express melatonin receptor MT1, but not melatonin receptor MT2: a new perspective to neuroprotection. 2011, Pubmed
Kelso, Melatonin and minocycline for combinatorial therapy to improve functional and histopathological deficits following traumatic brain injury. 2011, Pubmed
Kline, Combination therapies for neurobehavioral and cognitive recovery after experimental traumatic brain injury: Is more better? 2016, Pubmed
Kota, Propranolol and Mesenchymal Stromal Cells Combine to Treat Traumatic Brain Injury. 2016, Pubmed
Kovesdi, Acute minocycline treatment mitigates the symptoms of mild blast-induced traumatic brain injury. 2012, Pubmed
Kumar, Neuroinflammation after traumatic brain injury: opportunities for therapeutic intervention. 2012, Pubmed
Li, Progesterone increases circulating endothelial progenitor cells and induces neural regeneration after traumatic brain injury in aged rats. 2012, Pubmed
Li, Myocyte enhancer factor 2C as a neurogenic and antiapoptotic transcription factor in murine embryonic stem cells. 2008, Pubmed
Liao, Autologous bone marrow mononuclear cells reduce therapeutic intensity for severe traumatic brain injury in children. 2015, Pubmed
Lin, Melatonin attenuates traumatic brain injury-induced inflammation: a possible role for mitophagy. 2016, Pubmed
Lin, The role of secreted factors in stem cells-mediated immune regulation. 2018, Pubmed
Liska, Granulocyte-colony stimulating factor and umbilical cord blood cell transplantation: Synergistic therapies for the treatment of traumatic brain injury. 2017, Pubmed
Liu, Mouse-induced pluripotent stem cells generated under hypoxic conditions in the absence of viral infection and oncogenic factors and used for ischemic stroke therapy. 2014, Pubmed
Liu, Human umbilical cord stem cells ameliorate experimental autoimmune encephalomyelitis by regulating immunoinflammation and remyelination. 2013, Pubmed
Loane, Neuroprotection for traumatic brain injury: translational challenges and emerging therapeutic strategies. 2010, Pubmed
Lozano, Neuroinflammatory responses to traumatic brain injury: etiology, clinical consequences, and therapeutic opportunities. 2015, Pubmed
Maas, Moderate and severe traumatic brain injury in adults. 2008, Pubmed
Maiti, Transplantation of mesenchymal stem cells overexpressing interleukin-10 induces autophagy response and promotes neuroprotection in a rat model of TBI. 2019, Pubmed
Mashkouri, Utilizing pharmacotherapy and mesenchymal stem cell therapy to reduce inflammation following traumatic brain injury. 2016, Pubmed
Matsubara, Estrogen and progesterone play pivotal roles in endothelial progenitor cell proliferation. 2012, Pubmed
Matsumoto, [Orthodontic treatment for 3 impacted upper anterior teeth]. 1986, Pubmed
Neal, Regulatory T-cells within bone marrow-derived stem cells actively confer immunomodulatory and neuroprotective effects against stroke. 2019, Pubmed
Neuwelt, Engaging neuroscience to advance translational research in brain barrier biology. 2011, Pubmed
Nudi, Combining Enriched Environment, Progesterone, and Embryonic Neural Stem Cell Therapy Improves Recovery after Brain Injury. 2015, Pubmed
Németh, Bone marrow stromal cells attenuate sepsis via prostaglandin E(2)-dependent reprogramming of host macrophages to increase their interleukin-10 production. 2009, Pubmed
Offit, Passive protection against rotavirus-induced diarrhea by monoclonal antibodies to surface proteins vp3 and vp7. 1986, Pubmed
Okie, Traumatic brain injury in the war zone. 2005, Pubmed
Pabón, Brain Region-Specific Histopathological Effects of Varying Trajectories of Controlled Cortical Impact Injury Model of Traumatic Brain Injury. 2016, Pubmed
Patel, Long noncoding RNA MALAT1 in exosomes drives regenerative function and modulates inflammation-linked networks following traumatic brain injury. 2018, Pubmed
Patel, Adipose-derived stem cells from lean and obese humans show depot specific differences in their stem cell markers, exosome contents and senescence: role of protein kinase C delta (PKCδ) in adipose stem cell niche. 2016, Pubmed
Peruzzaro, Transplantation of mesenchymal stem cells genetically engineered to overexpress interleukin-10 promotes alternative inflammatory response in rat model of traumatic brain injury. 2019, Pubmed
Prasad, Intravenous autologous bone marrow mononuclear stem cell therapy for ischemic stroke: a multicentric, randomized trial. 2014, Pubmed
Ransohoff, A polarizing question: do M1 and M2 microglia exist? 2016, Pubmed
Rodrigues, Recent progress in cell therapy for basal ganglia disorders with emphasis on menstrual blood transplantation in stroke. 2012, Pubmed
Russo, Effects of neuroinflammation on the regenerative capacity of brain stem cells. 2011, Pubmed
Seabra, Randomized, double-blind clinical trial, controlled with placebo, of the toxicology of chronic melatonin treatment. 2000, Pubmed
Shahror, Enhanced Homing of Mesenchymal Stem Cells Overexpressing Fibroblast Growth Factor 21 to Injury Site in a Mouse Model of Traumatic Brain Injury. 2019, Pubmed
Shlosberg, Blood-brain barrier breakdown as a therapeutic target in traumatic brain injury. 2010, Pubmed
Skop, Optimizing a multifunctional microsphere scaffold to improve neural precursor cell transplantation for traumatic brain injury repair. 2016, Pubmed
Steinberg, Clinical Outcomes of Transplanted Modified Bone Marrow-Derived Mesenchymal Stem Cells in Stroke: A Phase 1/2a Study. 2016, Pubmed
Stroemer, The neural stem cell line CTX0E03 promotes behavioral recovery and endogenous neurogenesis after experimental stroke in a dose-dependent fashion. 2009, Pubmed
Tajiri, Stem cell-paved biobridge facilitates neural repair in traumatic brain injury. 2014, Pubmed
Tajiri, Stem cell recruitment of newly formed host cells via a successful seduction? Filling the gap between neurogenic niche and injured brain site. 2013, Pubmed
Tajiri, Adult stem cell transplantation: is gender a factor in stemness? 2014, Pubmed
Tajiri, Intravenous transplants of human adipose-derived stem cell protect the brain from traumatic brain injury-induced neurodegeneration and motor and cognitive impairments: cell graft biodistribution and soluble factors in young and aged rats. 2014, Pubmed
Takemoto, Pleiotropic effects of 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibitors. 2001, Pubmed
Tan, [Effect of chitosan porous scaffolds combined with bone marrow mesenchymal stem cells in repair of neurological deficit after traumatic brain injury in rats]. 2018, Pubmed
Tapia-Perez, Effect of rosuvastatin on amnesia and disorientation after traumatic brain injury (NCT003229758). 2008, Pubmed
Tunc Ata, Effect of Erythropoietin and Stem Cells on Traumatic Brain Injury. 2016, Pubmed
Uekawa, Rosuvastatin ameliorates early brain injury after subarachnoid hemorrhage via suppression of superoxide formation and nuclear factor-kappa B activation in rats. 2014, Pubmed
Valadi, Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells. 2007, Pubmed
Vasandan, Human Mesenchymal stem cells program macrophage plasticity by altering their metabolic status via a PGE2-dependent mechanism. 2016, Pubmed
Wang, Melatonin alleviates secondary brain damage and neurobehavioral dysfunction after experimental subarachnoid hemorrhage: possible involvement of TLR4-mediated inflammatory pathway. 2013, Pubmed
Wang, Simvastatin and atorvastatin improve behavioral outcome, reduce hippocampal degeneration, and improve cerebral blood flow after experimental traumatic brain injury. 2007, Pubmed
Wang, Simvastatin attenuates the cerebral vascular endothelial inflammatory response in a rat traumatic brain injury. 2014, Pubmed
Watanabe, Administration of TSG-6 improves memory after traumatic brain injury in mice. 2013, Pubmed
Wei, Intracranial Transplantation of Hypoxia-Preconditioned iPSC-Derived Neural Progenitor Cells Alleviates Neuropsychiatric Defects After Traumatic Brain Injury in Juvenile Rats. 2016, Pubmed
Werner, Pathophysiology of traumatic brain injury. 2007, Pubmed
Wu, Attenuation of astrogliosis and modulation of endothelial growth factor receptor in lipid rafts by simvastatin after traumatic brain injury. 2010, Pubmed
Yu, Progesterone-mediated angiogenic activity of endothelial progenitor cell and angiogenesis in traumatic brain injury rats were antagonized by progesterone receptor antagonist. 2017, Pubmed
Zhang, Anti-inflammatory and immunomodulatory mechanisms of mesenchymal stem cell transplantation in experimental traumatic brain injury. 2013, Pubmed
Zhao, Sulforaphane enhances aquaporin-4 expression and decreases cerebral edema following traumatic brain injury. 2005, Pubmed
Zibara, Combination of drug and stem cells neurotherapy: Potential interventions in neurotrauma and traumatic brain injury. 2019, Pubmed
Ziebell, Involvement of pro- and anti-inflammatory cytokines and chemokines in the pathophysiology of traumatic brain injury. 2010, Pubmed
de la Peña, Umbilical cord blood cell and granulocyte-colony stimulating factor: combination therapy for traumatic brain injury. 2014, Pubmed